Evidence map›Paper›PMID 40666934›Full record

ArticlebioRxiv : the preprint server for biology2025

Protocol for spatial characterization of ECM collagen-GAG in CRC tumor microenvironment.

Libby A Boykin, Sneha Jayashankar, Khidr Kishan K Budhwani, Brahma Mubarak K Budhwani, Diya Samal, Chelsea L Crawford, Allan Tsung, Karim I Budhwani

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Libby A BoykinCerFlux, Birmingham, AL, USA.
Sneha JayashankarCerFlux, Birmingham, AL, USA.
Khidr Kishan K BudhwaniCerFlux, Birmingham, AL, USA.
Brahma Mubarak K BudhwaniCerFlux, Birmingham, AL, USA.
Diya SamalCerFlux, Birmingham, AL, USA.
Chelsea L CrawfordCerFlux, Birmingham, AL, USA.
Allan TsungDepartment of Surgery, University of Virginia School of Medicine, Charlottesville, VA, USA.
Karim I BudhwaniCerFlux, Birmingham, AL, USA.ORCID 0000-0001-8823-1695

Funding

Development of personalized ex vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment.R43CA254493 · NCI · CERFLUX, INC. · PI BUDHWANI, KARIM I · 2020 to 2021
$301k
NCI NIH HHS R43 CA254493
6 · The paper itself

Abstract

The extracellular matrix (ECM) plays a critical role in colorectal cancer (CRC) progression and therapeutic resistance. Accurate characterization of ECM composition and architecture is essential for understanding how CRC evades therapy, yet most protocols either assess ECM components in isolation or remain technically challenging. Here we present a robust yet simple protocol for spatial characterization of collagen and glycosaminoglycan (GAG) organization within the CRC tumor microenvironment (TME). Our method combines Alcian Blue and Picrosirius Red staining procedures with standardized tissue processing and imaging protocols. The protocol enables simultaneous visualization, assessment, and quantification of collagen and GAG distribution patterns in formalin-fixed, paraffin-embedded tissue sections. Key methodological advances include optimized dual-staining approach with distinct blue-red coloration for straightforward spectral separation on digital imaging systems, standardized reagent preparations, and validated imaging parameters. The complementary wavelengths facilitate both visual interpretation and potential digital separation, offering advantages over multi-component stains with overlapping spectral ranges. Validation across multiple CRC patient specimens demonstrates excellent reproducibility with consistent staining intensity using standard histology equipment. Because the resulting spatial maps can be compared directly with engineered or

Indexed as

Alcian bluecollagencolorectal cancer (CRC)dual-stain protocolextracellular matrix (ECM)glycosaminoglycans (GAGs)picrosirius redtumor microenvironment (TME)

Identifiers

PMID40666934
PMCPMC12262417

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.